Identification of new therapeutic targets in plasma cells and multiple myeloma
This project will characterise 3 newly identified molecules that are highly expressed on both normal and malignant plasma cells. We will study their normal biology and will attempt to target them with monoclonal antibodies as a step towards new therapies for multiple myeloma and autoimmune diseases.
Prof Stephen Nutt, A/Prof Lynn Corcoran
Cancer Council Research Grant
Walter and Eliza Hall Institute of Medical Research, Molecular Immunology Division
$99,800 in 2016, $100,000 pa 2017 and 2018